The role of cancer stem cells in neoplasia of the lung: Past, present and future

Clinical and Translational Oncology

Volumn 10, Issue 11, 2008, Pages 719-725

  Yagui Beltrán, Adam ^a   He, Biao ^a   Jablons, David M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer stem cells; Cell surface markers; Lung cancer; Microenvironment; Novel therapies; Stem cells

Indexed keywords

DIFFERENTIATION ANTIGEN; NOTCH RECEPTOR; SONIC HEDGEHOG PROTEIN; TUMOR MARKER; TUMOR PROTEIN; WNT PROTEIN;

ANIMAL; CANCER STEM CELL; CANCER TRANSPLANTATION; CELL TRANSFORMATION; FORECASTING; GENE EXPRESSION PROFILING; GENETICS; HUMAN; LUNG TUMOR; MOUSE; MOUSE MUTANT; MUTATION; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; ANTIGENS, DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; FORECASTING; GENE EXPRESSION PROFILING; HEDGEHOG PROTEINS; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED NOD; MICE, SCID; MUTATION; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; STEM CELLS; TUMOR MARKERS, BIOLOGICAL; WNT PROTEINS;

EID: 59249106989     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-008-0278-6     Document Type: Review

References (104)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43-66
3. Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3:730-737
4. O'Brien CA, Pollett A, Gallinger S, Dick JE (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106-110
5. Ricci-Vitiani L, Lombardi DG, Pilozzi E et al (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445:111-115
6. Lapidot T, Sirard C, Vormoor J et al (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367:645-648
7. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100:3983-3988
8. Singh SK, Hawkins C, Clarke ID et al (2004) Identification of human brain tumour initiating cells. Nature 432:396-401
9. Li C, Heidt DG, Dalerba P et al (2007) Identification of pancreatic cancer stem cells. Cancer Res 67:1030-1037
10. Prince ME, Sivanandan R, Kaczorowski A et al (2007) Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 104:973-978
11. Dalerba P, Dylla SJ, Park IK et al (2007) Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A 104:10158-10163
12. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105-111
13. Pardal R, Clarke MF, Morrison SJ (2003) Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 3:895-902
14. Wicha MS, Liu S, Dontu G (2006) Cancer stem cells: an old idea-a paradigm shift. Cancer Res 66:1883-1890; discussion 1895-1896
15. Rawlins EL, Hogan BL (2006) Epithelial stem cells of the lung: privileged few or opportunities for many? Development 133:2455-2465
16. Berns A (2005) Stem cells for lung cancer? Cell 121:811-813
17. Hong KU, Reynolds SD, Giangreco A, Hurley CM, Stripp BR (2001) Clara cell secretory protein-expressing cells of the airway neuroepithelial body microenvironment include a label-retaining subset and are critical for epithelial renewal after progenitor cell depletion. Am J Respir Cell Mol Biol 24:671-681
18. Benitah SA, Frye M, Glogauer M, Watt FM (2005) Stem cell depletion through epidermal deletion of Rac1. Science 309:933-935
19. Blair A, Hogge DE, Ailles LE, Lansdorp PM, Sutherland HJ (1997) Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. Blood 89:3104-3112
20. Passegue E, Jamieson CH, Ailles LE, Weissman IL (2003) Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc Natl Acad Sci U S A 100[Suppl 1]:11842-11849
21. Kondo T, Setoguchi T, Taga T (2004) Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci U S A 101:781-786
22. Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG (2005) Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2-cancer cells are similarly tumorigenic. Cancer Res 65:6207-6219
23. Hirschmann-Jax C, Foster AE, Wulf GG, Goodell MA, Brenner MK (2005) A distinct "side population" of cells in human tumor cells: implications for tumor biology and therapy. Cell Cycle 4:203-205
24. Galli R, Binda E, Orfanelli U et al (2004) Isolation and characterization of tumorigenic, stemlike neural precursors from human glioblastoma. Cancer Res 64:7011-7021
25. Hemmati HD, Nakano I, Lazareff JA et al (2003) Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A 100: 15178-15183
26. Hochedlinger K, Yamada Y, Beard C, Jaenisch R (2005) Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121:465-477
27. Fisher GH, Wellen SL, Klimstra D et al (2001) Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev 15:3249-3262
28. .Lo Celso C, Prowse DM, Watt FM (2004) Transient activation of beta-catenin signalling in adult mouse epidermis is sufficient to induce new hair follicles but continuous activation is required to maintain hair follicle tumours. Development 131:1787-1799
29. Barrandon Y, Morgan JR, Mulligan RC, Green H (1989) Restoration of growth potential in paraclones of human keratinocytes by a viral oncogene. Proc Natl Acad Sci U S A 86:4102-4106
30. Pelengaris S, Littlewood T, Khan M, Elia G, Evan G (1999) Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol Cell 3:565-577
31. Owens DM, Watt FM (2003) Contribution of stem cells and differentiated cells to epidermal tumours. Nat Rev Cancer 3:444-451
32. Meuwissen R, Berns A (2005) Mouse models for human lung cancer. Genes Dev 19:643-664
33. Franklin WA, Gazdar AF, Haney J et al (1997) Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. J Clin Invest 100:2133-2137
34. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH et al (2003) A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 63:1727-1730
35. Meuwissen R, Linn SC, van der Valk M, Mooi WJ, Berns A et al (2001) Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene. Oncogene 20:6551-6558
36. Johnson L, Mercer K, Greenbaum D et al (2001) Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410: 1111-1116
37. Jackson EL, Willis N, Mercer K et al (2001) Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 15:3243-3248
38. Guerra C, Mijimolle N, Dhawahir A et al (2003) Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell 4:111-120
39. Giangreco A, Groot KR, Janes SM (2007) Lung cancer and lung stem cells: strange bedfellows? Am J Respir Crit Care Med 175:547-553
40. Giangreco A, Shen H, Reynolds SD, Stripp BR (2004) Molecular phenotype of airway side population cells. Am J Physiol Lung Cell Mol Physiol 286:L624-630
41. Williams BO, Remington L, Albert DM, Mukai S, Bronson RT, Jacks T (1994) Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat Genet 7:480-484
42. Wikenheiser-Brokamp KA (2004) Rb family proteins differentially regulate distinct cell lineages during epithelial development. Development 131:4299-4310
43. Meuwissen R, Linn SC, Linnoila RI, Zevenhoven J, Mooi WJ, Berns A (2003) Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell 4:181-189
44. Minna JD, Kurie JM, Jacks T (2003) A big step in the study of small cell lung cancer. Cancer Cell 4:163-166
45. Reynolds SD, Giangreco A, Power JH, Stripp BR (2000) Neuroepithelial bodies of pulmonary airways serve as a reservoir of progenitor cells capable of epithelial regeneration. Am J Pathol 156:269-278
46. Linnoila RI, Naizhen X, Meuwissen R, Berns A, DeMayo FJ (2005) Mouse lung neuroendocrine carcinomas: distinct morphologies, same transcription factors. Exp Lung Res 31:37-55
47. Linnoila RI, Sahu A, Miki M, Ball DW, DeMayo FJ (2000) Morphometric analysis of CC10-hASH1 transgenic mouse lung: a model for bronchiolization of alveoli and neuroendocrine carcinoma. Exp Lung Res 26:595-615
48. Van Lommel A, Bolle T, Fannes W, Lauweryns JM (1999) The pulmonary neuroendocrine system: the past decade. Arch Histol Cytol 62:1-16
49. Miller LA, Wert SE, Whitsett JA (2001) Immunolocalization of sonic hedgehog (Shh) in developing mouse lung. J Histochem Cytochem 49:1593-1604
50. Watkins DN, Berman DM, Burkholder SG, Wang B, Beachy PA, Baylin SB (2003) Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 422:313-317
51. Collins BJ, Kleeberger W, Ball DW (2004) Notch in lung development and lung cancer. Semin Cancer Biol 14:357-364
52. Ball DW, Azzoli CG, Baylin SB et al (1993) Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors. Proc Natl Acad Sci U S A 90:5648-5652
53. Kim CF, Jackson EL, Woolfenden AE et al (2005) Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121:823-835
54. Politi K, Zakowski MF, Fan PD, Schonfeld EA, Pao W, Varmus HE (2006) Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors. Genes Dev 20:1496-1510
55. Ji H, Li D, Chen L et al (2006) The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies. Cancer Cell 9:485-495
56. Bottinger EP, Jakubczak JL, Haines DC, Bagnall K, Wakefield LM (1997) Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[ a]-anthracene. Cancer Res 57:5564-5570
57. Wikenheiser KA, Clark JC, Linnoila RI, Stahlman MT, Whitsett JA (1992) Simian virus 40 large T antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice. Cancer Res 52:5342-5352
58. DeMayo FJ, Finegold MJ, Hansen TN, Stanley LA, Smith B, Bullock DW (1991) Expression of SV40 T antigen under control of rabbit uteroglobin promoter in transgenic mice. Am J Physiol 261:L70-76
59. Carney DN, Gazdar AF, Bunn PA, Jr., Guccion JG (1982) Demonstration of the stem cell nature of clonogenic tumor cells from lung cancer patients. Stem Cells 1:149-164
60. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC (1996) Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 183:1797-1806
61. Gutova M, Najbauer J, Gevorgyan A et al (2007) Identification of uPAR-positive chemoresistant cells in small cell lung cancer. PLoS ONE 2:e243
62. Ho MM, Ng AV, Lam S, Hung JY (2007) Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 67:4827-4833
63. Lowry WE, Richter L (2007) Signaling in adult stem cells. Front Biosci 12: 3911-3927
64. Liu J, Jiang G (2006) CD44 and hematologic malignancies. Cell Mol Immunol 3:359-365
65. Naor D, Nedvetzki S, Golan I, Melnik L, Faitelson Y (2002) CD44 in cancer. Crit Rev Clin Lab Sci 39:527-579
66. Desai B, Rogers MJ, Chellaiah MA (2007) Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells. Mol Cancer 6:18
67. Le QT, Chen E, Salim A et al (2006) An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers. Clin Cancer Res 12:1507-1514
68. Lee LN, Kuo SH, Lee YC et al (2005) CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma. J Formos Med Assoc 104:541-548
69. Shmelkov SV, St Clair R, Lyden D, Rafii S (2005) AC133/CD133/Prominin-1. Int J Biochem Cell Biol 37:715-719
70. Vescovi AL, Galli R, Reynolds BA (2006) Brain tumour stem cells. Nat Rev Cancer 6:425-436
71. Beier D, Hau P, Proescholdt M et al (2007) CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67:4010-4015
72. Eramo A, Lotti F, Sette G et al (2008) Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15:504-514
73. Hibi K, Takahashi T, Sekido Y et al (1991) Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer. Oncogene 6:2291-2296
74. Pelosi G, Barisella M, Pasini F et al (2004) CD117 immunoreactivity in stage I adenocarcinoma and squamous cell carcinoma of the lung: relevance to prognosis in a subset of adenocarcinoma patients. Mod Pathol 17:711-721
75. Altundag O, Altundag K, Boruban C, Silay YS, Turen S (2005) Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: a Phase II clinical trial. Cancer 104:2033-2034; author reply 2034
76. Dy GK, Miller AA, Mandrekar SJ et al (2005) A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG study. Ann Oncol 16:1811-1816
77. Gross D.J., Munter G., Bitan M., et al. The role of imatinib mesylate (glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R. Endocr Relat Cancer 13: 535-540
78. Romer J, Nielsen BS, Ploug M (2004) The urokinase receptor as a potential target in cancer therapy. Curr Pharm Des 10:2359-2376
79. Liu H, Kho AT, Kohane IS, Sun Y (2006) Predicting survival within the lung cancer histopathological hierarchy using a multi-scale genomic model of development. PLoS Med 3:e232
80. Virchow R (1858) Die Cellularpathologie in ihrer Begründung auf physiologische und pathologische Gewebelehre. Berlin
81. Rijsewijk F, Schuermann M, Wagenaar E, Parren P, Weigel D, Nusse R (1987) The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell 50:649-657
82. Wang Z, Shu W, Lu MM, Morrisey EE (2005) Wnt7b activates canonical signaling in epithelial and vascular smooth muscle cells through interactions with Fzd1, Fzd10, and LRP5. Mol Cell Biol 25:5022-5030
83. Lako M, Strachan T, Bullen P, Wilson DI, Robson SC, Lindsay S (1998) Isolation, characterisation and embryonic expression of WNT11, a gene which maps to 11q13.5 and has possible roles in the development of skeleton, kidney and lung. Gene 219:101-110
84. Li C, Xiao J, Hormi K, Borok Z, Minoo P (2002) Wnt5a participates in distal lung morphogenesis. Dev Biol 248:68-81
85. Shu W, Jiang YQ, Lu MM, Morrisey EE (2002) Wnt7b regulates mesenchymal proliferation and vascular development in the lung. Development 129:4831-4842
86. Widelitz R (2005) Wnt signaling through canonical and non-canonical pathways: recent progress. Growth Factors 23:111-116
87. Akiyama T (2000) Wnt/beta-catenin signaling. Cytokine Growth Factor Rev 11:273-282
88. Veeman MT, Axelrod JD, Moon RT (2003) A second canon. Functions and mechanisms of beta-ca - tenin-independent Wnt signaling. Dev Cell 5: 367-377
89. De Langhe SP, Sala FG, Del Moral PM et al (2005) Dickkopf-1 (DKK1) reveals that fibronectin is a major target of Wnt signaling in branching morphogenesis of the mouse embryonic lung. Dev Biol 277:316-331
90. You L, He B, Xu Z et al (2004) Inhibition of Wnt- 2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells. Oncogene 23:6170-6174
91. Kim J, You L, Xu Z et al (2007) Wnt inhibitory factor inhibits lung cancer cell growth. J Thorac Cardiovasc Surg 133:733-737
92. He B, Barg RN, You L et al (2005) Wnt signaling in stem cells and non-small-cell lung cancer. Clin Lung Cancer 7:54-60
93. Uematsu K, He B, You L, Xu Z, McCormick F, Jablons DM (2003) Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene 22:7218-7221
94. Bettenhausen B, Hrabe de Angelis M, Simon D, Guenet JL, Gossler A (1995) Transient and restricted expression during mouse embryogenesis of Dll1, a murine gene closely related to Drosophila Delta. Development 121:2407-2418
95. Juopperi TA, Schuler W, Yuan X, Collector MI, Dang CV, Sharkis SJ (2007) Isolation of bone marrow-derived stem cells using density-gradient separation. Exp Hematol 35:335-341
96. Post LC, Ternet M, Hogan BL (2000) Notch/Delta expression in the developing mouse lung. Mech Dev 98:95-98
97. Chen H, Thiagalingam A, Chopra H et al (1997) Conservation of the Drosophila lateral inhibition pathway in human lung cancer: a hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expression. Proc Natl Acad Sci U S A 94:5355-5360
98. Dang TP, Gazdar AF, Virmani AK et al (2000) Chromosome 19 translocation, overexpression of Notch3, and human lung cancer. J Natl Cancer Inst 92:1355-1357
99. Varjosalo M, Taipale J (2007) Hedgehog signaling. J Cell Sci 120:3-6
100. van Tuyl M, Post M (2000) From fruitflies to mammals: mechanisms of signalling via the Sonic hedgehog pathway in lung development. Respir Res 1:30-35
101. Bellusci S, Furuta Y, Rush MG, Henderson R, Winnier G, Hogan BL (1997) Involvement of Sonic hedgehog (Shh) in mouse embryonic lung growth and morphogenesis. Development 124:53-63
102. Litingtung Y, Lei L, Westphal H, Chiang C (1998) Sonic hedgehog is essential to foregut development. Nat Genet 20:58-61
103. Reynolds SD, Hong KU, Giangreco A et al (2000) Conditional clara cell ablation reveals a self-renewing progenitor function of pulmonary neuroendocrine cells. Am J Physiol Lung Cell Mol Physiol 278:L1256-1263
104. Cooper MK, Porter JA, Young KE, Beachy PA (1998) Teratogen-mediated inhibition of target tissue response to Shh signaling. Science 280:1603-1607